home / stock / tpst / tpst articles

TPST Articles, Tempest Therapeutics Inc.

Stock Information
Company Name: Tempest Therapeutics Inc.
Stock Symbol: TPST
Market: NASDAQ
Menu
TPST TPST Quote TPST Short TPST News TPST Articles TPST Message Board
Get TPST Alerts

News, Short Squeeze, Breakout and More Instantly...
Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining more than 300 points on Thursday. The Dow traded up 0.87% to 3...
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 20...

Gold Rises 1%; Accenture Shares Surge After Q3 Results | Benzinga

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 50 points on Thursday. Following the market opening Thursd...

What's Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday? | Benzinga

Shares of Tempest Therapeutics Inc (NASDAQ:TPST) are trading lower on Thursday, with a session volume of 21 million as per data from Benzinga Pro. ...
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with ...

Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm | Benzinga

21 months median OS in amezalpat arm vs. 15 in control arm 50% (20/40) of patients on amezalpat arm remain in survival follow up 0.65 hazard r...

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma | Benzinga

BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company developing ...
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...

Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types | Benzinga

BRISBANE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company developing...

Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting | Benzinga

BRISBANE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company developing...
Next 10